Page last updated: 2024-11-12
bimosiamose disodium
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
bimosiamose disodium: selectin inhibitor; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 11520819 |
CHEMBL ID | 2146099 |
MeSH ID | M0578218 |
Synonyms (21)
Synonym |
---|
D03114 , |
187269-60-9 |
bimosiamose disodium (usan) |
bimosiamose disodium |
tbc1269z |
7ak2fkb9aw , |
disodium 3',3'''-hexamethylenebis(6'-alpha-d-mannopyranosyloxy)-3-biphenylacetate) |
(1,1'-biphenyl)-3-acetic acid, 3',3'''-(1,6-hexanedidyl)bis(6'-(alpha-d-mannopyranosyloxy)-, disodium salt |
bimosiamose disodium [usan] |
(1,1'-biphenyl)-3-acetic acid, 3',3'''-(1,6-hexanediyl)bis(6'-(alpha-d-mannopyranosyloxy)-, disodium salt |
unii-7ak2fkb9aw |
bimosiamose disodium salt |
tbc-1269z |
CHEMBL2146099 |
(1,1'-biphenyl)-3-acetic acid, 3',3'''-(1,6-hexanediyl)bis(6'-(.alpha.-d-mannopyranosyloxy)-, disodium salt |
bimosiamose disodium salt [mi] |
disodium 3',3'''-hexamethylenebis(6'-.alpha.-d-mannopyranosyloxy)-3-biphenylacetate) |
disodium;2-[3-[5-[6-[3-[3-(carboxylatomethyl)phenyl]-4-[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]hexyl]-2-[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]phenyl]acetate |
Q27266838 |
sodium 2,2'-(hexane-1,6-diylbis(6'-(((2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)-[1,1'-biphenyl]-3',3-diyl))diacetate |
disodium 2-[3-[5-[6-[3-[3-(carboxymethyl)phenyl]-4-[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]hexyl]-2-[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]phenyl]acetate |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (24)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (20.83) | 18.2507 |
2000's | 19 (79.17) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 11.18
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.18) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 1 (4.00%) | 5.53% |
Reviews | 3 (12.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 21 (84.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |